Filtros de búsqueda

Lista de obras de

A sarcoma at the site of previous extravasation of adriamycin

artículo científico publicado en 2002

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site

artículo científico publicado en 2004

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

artículo científico publicado en 2006

Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography

artículo científico publicado en 2006

Gastrointestinal stromal tumor of the prostate

artículo científico publicado en 2005

Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity

artículo científico publicado en 2004

Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials

artículo científico publicado en 2010

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

artículo científico publicado en 2005

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2006

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

artículo científico publicado en 2005

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

artículo científico publicado en 2006

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Tria

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda